OABI

MKT CAP:$166M

OmniAb, Inc.

Market Cap

$166M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.56-$0.32 (-17.02%)

Apr 23, 2026

Company Details

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technolog...

CEO

Matthew W. Foehr

IPO Date

Sep 30, 2021

Website

www.omniab.com

Key Metrics TTM

Revenue

$19M

-29.3% YoY

Net Income

-$65M

EPS (Diluted)

-$0.57

Free Cash Flow

-$37M

Revenue / Share

$0.15

Gross Margin

73.5%

Operating Margin

-369.0%

Net Margin

-347.0%

FCF Margin

-198.3%

P/S

8.9x

P/E

—

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Mar 4, 2026

$19M-29.3%EPS -$0.57

Q4 2025

Mar 4, 2026

$8M-22.5%EPS -$0.11

Q3 2025

Nov 4, 2025

$2M-46.3%EPS -$0.14

Q2 2025

Aug 6, 2025

$4M-48.8%EPS -$0.15

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$10M	$6M	-$9M
Q2 22	$7M	$3M	-$12M
Q3 22	$7M	$2M	-$15M
Q4 22	$35M	$32M	$9M
Q1 23	$17M	$13M	-$8M
Q2 23	$7M	$2M	-$19M
Q3 23	$5M	$633.0K	-$20M
Q4 23	$5M	$5M	-$21M
Q1 24	$4M	$4M	-$23M
Q2 24	$8M	$8M	-$16M
Q3 24	$4M	$4M	-$20M
Q4 24	$11M	$11M	-$16M
Q1 25	$4M	$4M	-$19M
Q2 25	$4M	$4M	-$16M
Q3 25	$2M	-$2M	-$18M
Q4 25	$8M	$8M	-$16M

Valuation

Quarter	P/S	P/E
Q1 22	3.7x	—
Q2 22	4.3x	—
Q3 22	4.2x	—
Q4 22	2.8x	—
Q1 23	2.5x	—
Q2 23	2.5x	—
Q3 23	2.6x	—
Q4 23	4.8x	—
Q1 24	7.9x	—
Q2 24	7.6x	—
Q3 24	8.1x	—
Q4 24	6.3x	—
Q1 25	6.2x	—
Q2 25	7.2x	—
Q3 25	7.9x	—
Q4 25	8.9x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$12M	$8M
Q2 22	-$4M	-$8M
Q3 22	-$4M	-$8M
Q4 22	-$3M	-$20M
Q1 23	$28M	$27M
Q2 23	-$10M	-$11M
Q3 23	-$6M	-$7M
Q4 23	-$9M	-$9M
Q1 24	-$17M	-$18M
Q2 24	-$12M	-$13M
Q3 24	-$7M	-$7M
Q4 24	-$4M	-$4M
Q1 25	-$16M	-$16M
Q2 25	-$5M	-$5M
Q3 25	-$10M	-$10M
Q4 25	-$6M	-$6M

Capital Expenditures

Quarter	CapEx
Q1 22	$4M
Q2 22	$4M
Q3 22	$4M
Q4 22	$17M
Q1 23	$234.0K
Q2 23	$813.0K
Q3 23	$490.0K
Q4 23	$107.0K
Q1 24	$926.0K
Q2 24	$751.0K
Q3 24	$152.0K
Q4 24	$46.0K
Q1 25	$209.0K
Q2 25	$165.0K
Q3 25	$182.0K
Q4 25	$9.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+93.0%	+37.6%
Q2 22	-46.0%	+24.7%
Q3 22	+4.8%	+29.9%
Q4 22	+131.3%	+42.0%
Q1 23	+75.8%	+38.5%
Q2 23	-3.5%	+33.9%
Q3 23	-20.7%	+17.0%
Q4 23	-86.4%	-1.4%
Q1 24	-77.5%	+4.1%
Q2 24	+9.6%	-8.9%
Q3 24	-23.8%	-7.1%
Q4 24	+124.1%	+2.5%
Q1 25	+9.3%	-12.7%
Q2 25	-48.8%	-15.9%
Q3 25	-46.3%	-14.8%
Q4 25	-22.5%	-10.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$3M	32.7%
Q2 22	$4M	53.5%
Q3 22	$5M	76.4%
Q4 22	$0	0.0%
Q1 23	$6M	35.8%
Q2 23	$7M	94.0%
Q3 23	$6M	115.2%
Q4 23	$6M	122.9%
Q1 24	$6M	149.8%
Q2 24	$5M	70.7%
Q3 24	$5M	127.2%
Q4 24	$5M	47.4%
Q1 25	$4M	99.8%
Q2 25	$4M	105.5%
Q3 25	$0	0.0%
Q4 25	$4M	43.1%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 22	$11M	—	$4M
Q2 22	$11M	—	$4M
Q3 22	$13M	—	$4M
Q4 22	$13M	—	$10M
Q1 23	$14M	—	$7M
Q2 23	$14M	—	$7M
Q3 23	$14M	—	$7M
Q4 23	$15M	$8M	—
Q1 24	$15M	$8M	—
Q2 24	$14M	$8M	—
Q3 24	$13M	$7M	—
Q4 24	$13M	$7M	—
Q1 25	$13M	$8M	—
Q2 25	$11M	$8M	—
Q3 25	$10M	—	$5M
Q4 25	$14M	$7M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$434.6K	$0	$434.6K
Q2 22	$0	$0	$0
Q3 22	$19.8K	$0	$19.8K
Q4 22	$33M	$55M	$88M
Q1 23	$23M	$91M	$114M
Q2 23	$21M	$82M	$103M
Q3 23	$21M	$75M	$97M
Q4 23	$16M	$71M	$87M
Q1 24	$19M	$50M	$69M
Q2 24	$21M	$36M	$57M
Q3 24	$27M	$32M	$59M
Q4 24	$28M	$32M	$59M
Q1 25	$11M	$33M	$44M
Q2 25	$18M	$23M	$42M
Q3 25	$29M	$31M	$60M
Q4 25	$26M	$29M	$54M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	115M	0.0%	0.0%
Q2 22	115M	0.0%	0.0%
Q3 22	115M	0.0%	0.0%
Q4 22	94M	-18.4%	-18.4%
Q1 23	99M	+5.8%	-13.6%
Q2 23	99M	+0.3%	-13.3%
Q3 23	100M	+0.4%	-13.0%
Q4 23	100M	+0.3%	+6.9%
Q1 24	101M	+0.6%	+1.6%
Q2 24	101M	+0.7%	+2.0%
Q3 24	102M	+0.9%	+2.5%
Q4 24	105M	+2.3%	+4.6%
Q1 25	106M	+0.8%	+4.8%
Q2 25	106M	+0.5%	+4.6%
Q3 25	115M	+8.1%	+12.0%
Q4 25	128M	+11.4%	+21.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$1M	7
Q2 22	$1M	7
Q3 22	$987.1K	7
Q4 22	$372.1K	95
Q1 23	$178.1K	95
Q2 23	$73.1K	95
Q3 23	$57.7K	95
Q4 23	$45.5K	106
Q1 24	$35.9K	106
Q2 24	$71.8K	106
Q3 24	$39.4K	106
Q4 24	$94.8K	114
Q1 25	$36.4K	114
Q2 25	$34.2K	114
Q3 25	$19.6K	114
Q4 25	$94.1K	89

Revenue / Employee